Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wolfdog2 who wrote (1369)	10/9/1998 7:56:00 PM
From: David Israel-Rosen	Read Replies (4) of 1491

Ken: I agree that the next chance for a pop is when they sign a partner for the project. FACT - The REAL NEWS HERE IS THE CLINICAL IMPACT OF HU211 NOT THE DEATH RATE... However, I think that the release compared the mortality rate of the Placebo to the HU211 Sample which ACOMPLISHED one thing: It allowed the market to FOCUS on completely FACTUALLY useless information and not on the real DATA the PRESSURE. What was the value of the data on the 26% reduction in mortality ? The only relEvant mortality rate is how many death you expect in the population (25% ?) and how many did you have in the HU211 sample ? Given that both groups had low death rate what is the value of POINTING this out. POINTING the mortality rate OUT MADE IT POSSIBLE FOR PEOPLE TO focus on mortality and CONCLUDE that this was not a BIG DEAL... OTHERWISE the market would have been stuck with the only REAL DATA which relates to the PRESSURE... WHICH IS THE REAL BREAKTHROUGH HERE... A GOOD PR WOULD HAVE LEFT THE DEATH DATA TO THE SCIENTIFIC SESSION AND THE NEWS CONFERENCE, WHILE TALKING ABOUT the clinical impact of HU211...Pointing out the STATISTICAL SIGINIFICANCE OF THE DATA... KEN, WHAT DO YOU THINK REGARDS DAVID

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next